ODC1 and endometrial cancer: Kim et al. (2017) proposed ODC1 as a therapeutic target for inhibition for endometrial cancer, as it is often overexpressed and contributes to cell proliferation. Among the other similar nodes were the genetic risk for lung cancer (similarity score = 0.83) as well as for alcohol abuse (similarity score = 0.79) (Supplementary Figure S6B).